Skip to Main Content

Paper Details

Does ADT benefit unfavourable intermediate risk prostate cancer patients treated with brachytherapy boost and external beam radiotherapy? A propensity-score matched analysis.
Radiother Oncol
5
2020

Datasets

Release 1.2